Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

被引：8
|
作者：
Rizzo, Renata [1 ]
Martino, Davide [2 ,3 ]
机构：
[1] Univ Catania, Neuropsichiatria Infantile, Dipartimento Sci Med & Pediat, I-95123 Catania, Italy
[2] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England
[3] Queen Elizabeth Hosp, Lewisham & Greenwich NHS Trust, London, England
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2015年 / 15卷 / 04期
关键词：
alpha(2)-adrenoreceptor agonist; attention deficit hyperactivity disorder; guanfacine extended-release; guanfacine immediate-release; treatment; EXTENDED-RELEASE; DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; OPEN-LABEL; LONG-TERM; PHASE-I; ADHD; PHARMACOKINETICS; PSYCHOSTIMULANTS; NEUROBIOLOGY;
D O I：
10.1586/14737175.2015.1028370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Guanfacine is an (2A)-adrenoreceptor agonist currently indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This article reviews the chemistry, pharmacodynamics and pharmacokinetics of guanfacine, as well as the clinical trial literature on guanfacine for the treatment of ADHD in children and adolescents, mainly focusing on the use of guanfacine extended-release (GXR). Six already published prospective randomized controlled trials (RCTs) and one unpublished RCT study were identified for GXR in the treatment of ADHD. All RCTs trials showed superiority over placebo on the primary outcome measure. Guanfacine, especially XR, seems to be an effective and safe treatment option for ADHD in children and adolescents.
引用
收藏
页码：347 / 354
页数：8
相关论文
共 50 条
  • [41] Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Ozgen, Heval
    Spijkerman, Renske
    Noack, Moritz
    Holtmann, Martin
    Schellekens, Arnt
    Dalsgaard, Soren
    van den Brink, Wim
    Hendriks, Vincent
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [42] Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Luan, Ruiling
    Mu, Zhiling
    Yue, Fang
    He, Shaoying
    FRONTIERS IN PSYCHIATRY, 2017, 8
  • [43] Neurofeedback vs. Methylphenidate for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents
    Abenia Abenia, Ma Isabel
    Jimenez-Muro Franco, Adriana
    CUADERNOS DE NEUROPSICOLOGIA-PANAMERICAN JOURNAL OF NEUROPSYCHOLOGY, 2019, 13 (02): : 171 - 181
  • [44] Atomoxetine Treatment in Adolescents with Attention-Deficit/Hyperactivity Disorder
    Wietecha, Linda A.
    Williams, David W.
    Herbert, Michael
    Melmed, Raun D.
    Greenbaum, Michael
    Schuh, Kory
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 719 - 730
  • [45] Attention Deficit-Hyperactivity Disorder in Children and Adolescents
    Feldman, Heidi M.
    Reiff, Michael I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09): : 838 - 846
  • [46] Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder
    Bilder, Robert M.
    Loo, Sandra K.
    McGough, James J.
    Whelan, Fiona
    Hellemann, Gerhard
    Sugar, Catherine
    Del'Homme, Melissa
    Sturm, Alexandra
    Cowen, Jennifer
    Hanada, Grant
    McCracken, James T.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (08): : 667 - 673
  • [47] Guanfacine Extended Release Adjunctive to a Psychostimulant in the Treatment of Comorbid Oppositional Symptoms in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    McBurnett, Keith
    White, Carla
    Youcha, Sharon
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (05) : 245 - 252
  • [48] Venlafaxine in children and adolescents with attention deficit hyperactivity disorder
    Mukaddes, NM
    Abali, O
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (01) : 92 - 95
  • [49] Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications
    Hammerness, Paul G.
    Surman, Craig B. H.
    Chilton, Ashley
    CURRENT PSYCHIATRY REPORTS, 2011, 13 (05) : 357 - 363
  • [50] Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe
    Haege, A.
    Banaschewski, T.
    Dittmann, R. W.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (12) : 676 - 685
12345